Cargando…

Diagnostic Criteria for Fibromyalgia: Critical Review and Future Perspectives

Fibromyalgia syndrome (FMS) is a chronic illness characterized by widespread pain and other clinical and emotional symptoms. The lack of objective markers of the illness has been a persistent problem in FMS research, clinical management, and social recognition of the disease. A critical historical r...

Descripción completa

Detalles Bibliográficos
Autores principales: Galvez-Sánchez, Carmen M., Reyes del Paso, Gustavo A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230253/
https://www.ncbi.nlm.nih.gov/pubmed/32340369
http://dx.doi.org/10.3390/jcm9041219
_version_ 1783534906648821760
author Galvez-Sánchez, Carmen M.
Reyes del Paso, Gustavo A.
author_facet Galvez-Sánchez, Carmen M.
Reyes del Paso, Gustavo A.
author_sort Galvez-Sánchez, Carmen M.
collection PubMed
description Fibromyalgia syndrome (FMS) is a chronic illness characterized by widespread pain and other clinical and emotional symptoms. The lack of objective markers of the illness has been a persistent problem in FMS research, clinical management, and social recognition of the disease. A critical historical revision of diagnostic criteria for FMS, especially those formulated by the American College of Rheumatology (ACR), was performed. This narrative review has been structured as follows: Introduction; historical background of FMS, including studies proposing and revising the diagnostic criteria; the process of development of the ACR FMS diagnostic criteria (1990 and 2010 versions); revisions of the 2010 ACR FMS diagnostic criteria; the development of scales based on the 2010 and 2011 criteria, which could help with diagnosis and evaluation of the clinical severity of the disease, such as the Polysymptomatic Distress Scale and the FMS Survey Questionnaire; relationships of prevalence and sex ratio with the different diagnostic criteria; validity and diagnostic accuracy of the ACR FMS criteria; the issues of differential diagnosis and comorbidity; the strength and main limitations of the ACR FMS criteria; new perspectives regarding FMS diagnosis; and the impact of the novel findings in the diagnosis of FMS. It is concluded that despite the official 2010 FMS diagnostic criteria and the diagnostic proposal of 2011 and 2016, complaints from health professionals and patients continue.
format Online
Article
Text
id pubmed-7230253
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-72302532020-05-28 Diagnostic Criteria for Fibromyalgia: Critical Review and Future Perspectives Galvez-Sánchez, Carmen M. Reyes del Paso, Gustavo A. J Clin Med Review Fibromyalgia syndrome (FMS) is a chronic illness characterized by widespread pain and other clinical and emotional symptoms. The lack of objective markers of the illness has been a persistent problem in FMS research, clinical management, and social recognition of the disease. A critical historical revision of diagnostic criteria for FMS, especially those formulated by the American College of Rheumatology (ACR), was performed. This narrative review has been structured as follows: Introduction; historical background of FMS, including studies proposing and revising the diagnostic criteria; the process of development of the ACR FMS diagnostic criteria (1990 and 2010 versions); revisions of the 2010 ACR FMS diagnostic criteria; the development of scales based on the 2010 and 2011 criteria, which could help with diagnosis and evaluation of the clinical severity of the disease, such as the Polysymptomatic Distress Scale and the FMS Survey Questionnaire; relationships of prevalence and sex ratio with the different diagnostic criteria; validity and diagnostic accuracy of the ACR FMS criteria; the issues of differential diagnosis and comorbidity; the strength and main limitations of the ACR FMS criteria; new perspectives regarding FMS diagnosis; and the impact of the novel findings in the diagnosis of FMS. It is concluded that despite the official 2010 FMS diagnostic criteria and the diagnostic proposal of 2011 and 2016, complaints from health professionals and patients continue. MDPI 2020-04-23 /pmc/articles/PMC7230253/ /pubmed/32340369 http://dx.doi.org/10.3390/jcm9041219 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Galvez-Sánchez, Carmen M.
Reyes del Paso, Gustavo A.
Diagnostic Criteria for Fibromyalgia: Critical Review and Future Perspectives
title Diagnostic Criteria for Fibromyalgia: Critical Review and Future Perspectives
title_full Diagnostic Criteria for Fibromyalgia: Critical Review and Future Perspectives
title_fullStr Diagnostic Criteria for Fibromyalgia: Critical Review and Future Perspectives
title_full_unstemmed Diagnostic Criteria for Fibromyalgia: Critical Review and Future Perspectives
title_short Diagnostic Criteria for Fibromyalgia: Critical Review and Future Perspectives
title_sort diagnostic criteria for fibromyalgia: critical review and future perspectives
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230253/
https://www.ncbi.nlm.nih.gov/pubmed/32340369
http://dx.doi.org/10.3390/jcm9041219
work_keys_str_mv AT galvezsanchezcarmenm diagnosticcriteriaforfibromyalgiacriticalreviewandfutureperspectives
AT reyesdelpasogustavoa diagnosticcriteriaforfibromyalgiacriticalreviewandfutureperspectives